<H1>Chapter DOI: 10.1208/aapsj070478<br/>Cited-By Count: 8</H1><table border="1" width="30%"><tr><td>Total References</td><td>44</td></tr><tr><td>Springer references</td><td>2</td></tr><tr><td>Non Springer references</td><td>42</td></tr><tr><td>BibStructured Count</td><td width="10%">43</td></tr><tr><td>BibUnstructured Count</td><td width="10%">1</td></tr><tr><td>DOI already available in SpringerLink</td><td>30</td></tr><tr><td>Additional DOI extracted from CrossRef-Meta</td><td>3</td></tr><tr><td>Additional DOI extracted from CrossRef-Web</td><td>1</td></tr><tr><td>Additional DOI extracted from ResearchGate-Web</td><td>0</td></tr><tr><td>Additional DOI extracted from SpringerLink-FUZZY-Search</td><td>0</td></tr><tr><td>Spelling Mistakes</td><td>NULL</td></tr><tr><td>Wrong DOI</td><td>0</td></tr><tr><td>ISBN</td><td>NULL</td></tr><tr><td>Web Link</td><td>NULL</td></tr><tr><td>DOI Obtained For Springer Published</td><td>0</td></tr><tr><td>DOI Obtained For Non Springer</td><td>4</td></tr><tr><td>DOI Obtained From Structured Ref</td><td>4</td></tr><tr><td>DOI Obtained From Unstructured Ref</td><td>0</td></tr><tr><td>Valid DOI Enriched</td><td>1</td></tr></table></br></br><table border="1">
<tr><th>Bib. ID</th><th>Ref. Type</th><th>References</th><th>DOI</th><th>Suspected DOI</th><th>DOI Source</th><th>Validated Elements</th><th>Validation Source</th></tr><tr><td>CR1</td><td>BibBook</td><td>Griffin JF, Duax WL, eds.<Emphasis Type="Italic">Molecular Structure and Biological Activity</Emphasis>. New York, NY: Elsevier Biomedical; 1982.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/0022-2836(81)90090-5>10.1016/0022-2836(81)90090-5</a></td><td><b>CrossRef-Web</b></td>
<td>BookTitle</td><td>CrossRef</td></tr><tr><td>CR2</td><td>BibArticle</td><td>Hughes J, Smith TW, Kosterlitz HW, Fothergill LA, Morgan BA, Morris HR. Identification of 2 related pentapeptides from brain with potent opiate agonist activity.<Emphasis Type="Italic">Nature</Emphasis>. 1975;258:577&#8211;579.</td><td><a href=http://dx.doi.org/10.1038/258577a0>10.1038/258577a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR3</td><td>BibArticle</td><td>Temussi PA, Picone D, Castiglione-Morelli MA, Motta A, Tancredi T. Bioactive conformation of linear peptides in solution: an elusive goal.<Emphasis Type="Italic">Biopolymers</Emphasis>. 1989;28:91&#8211;107.</td><td><a href=http://dx.doi.org/10.1002/bip.360280112>10.1002/bip.360280112</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR4</td><td>BibArticle</td><td>Karle IL, Karle J, Mastropaolo D, Camerman A, Camerman N. [Leu-5]enkepalin-4 co-crystallizing conformers with extended backbones that form an anti-parallel beta-sheet.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1983;B39:625&#8211;637.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR5</td><td>BibArticle</td><td>Smith D, Griffin JF. Conformation of [Leu-5]enkephalin rrom X-ray-diffraction: features important for recognition at opiate receptor.<Emphasis Type="Italic">Science</Emphasis>. 1978;199:1214&#8211;1216.</td><td><a href=http://dx.doi.org/10.1126/science.204006>10.1126/science.204006</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR6</td><td>BibArticle</td><td>Aubry A, Birlirakis N, Sakarellos-Daitsiotis M, Sakarellos C, Marraud M. A crystal molecular-conformation of leucine-enkephalin related to the morphine molecule.<Emphasis Type="Italic">Biopolymers</Emphasis>. 1989;28:27&#8211;40.</td><td><a href=http://dx.doi.org/10.1002/bip.360280106>10.1002/bip.360280106</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR7</td><td>BibArticle</td><td>Doi M, Tanaka M, Ishida T, et al. Crystal-structures of [Met<Superscript>5</Superscript>] and [(4-bromo)Phe<Superscript>4</Superscript>,Met<Superscript>5</Superscript>]enkephalins: formation of a dimeric antiparallel beta-structure.<Emphasis Type="Italic">J Biochem (Tokyo)</Emphasis>, 1987;101:485&#8211;490.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR8</td><td>BibArticle</td><td>Loew GH. Molecular modeling of opioid analgesics.<Emphasis Type="Italic">Mod Drug Discovery</Emphasis>. 1999;2:24&#8211;30.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR9</td><td>BibUnstructured</td><td><span style='background:#FFD9B3'>SHELXTL [Computer program]. Version 6.10</span>. <span style='background:#C0FFC0'>Madison, Wisconsin</span>: <span style='background:#FFFF49'>Bruker AXS Inc</span>. <span style='background:#66FF66'>2000</span>.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR10</td><td>BibArticle</td><td>Griffin JF, Langs DA, Smith GD, Blundell TL, Tickle IJ, Bedarkar S. The crystal-structures of [Met<Superscript>5</Superscript>] enkephalin and a third form of [Leu<Superscript>5</Superscript>] enkephalin: observations of a novel pleated &#946;-sheet.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1986;83:3272&#8211;3276.</td><td><a href=http://dx.doi.org/10.1073/pnas.83.10.3272>10.1073/pnas.83.10.3272</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR11</td><td>BibArticle</td><td>Deschamps JR, Flippen-Anderson JL, Brine GA, Hayes JP, George C. Boc-tyrosyl-D-alanyl-glycyl-N-methyl-pnenylalanyl-O-methyl-methionine hydrate: a protected analog of metkephamid.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 2002;58E:o13-o15.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR12</td><td>BibArticle</td><td>Ishida T, Kenmotsu M, Mino Y, et al. X-Ray diffraction studies of enkephalins: crystal-structure of [(4&#8217;-bromo)Phe<Superscript>4</Superscript>,Leu<Superscript>5</Superscript>] enkephalin.<Emphasis Type="Italic">Biochem J</Emphasis>. 1984;218:677&#8211;689.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1042/bj2180677>10.1042/bj2180677</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, VolumeID, Author_FamilyName_1, FirstPage</td><td>CrossRef</td></tr><tr><td>CR13</td><td>BibArticle</td><td>Stezowski JJ, Eckle E, Bajusz SA. Crystal-structure determination for Tyr-d-Nle-Gly-Phe-Nles [Nles=MetCH<Subscript>2</Subscript>CH<Subscript>2</Subscript>CH<Subscript>2</Subscript>CH(NH<Subscript>2</Subscript>)SO<Subscript>3</Subscript>H]: an active synthetic enkephalin analog.<Emphasis Type="Italic">J Chem Soc Chem Comm</Emphasis>. 1985;11:681&#8211;682.</td><td><a href=http://dx.doi.org/10.1039/c39850000681>10.1039/c39850000681</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR14</td><td>BibArticle</td><td>Deschamps JR, George C, Flippen-Anderson JL. [D-Ala<Superscript>2</Superscript>, D-Leu<Superscript>5</Superscript>]-enkephalin (DADLE).<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1996;52:1583&#8211;1585.</td><td><a href=http://dx.doi.org/10.1107/S0108270196000534>10.1107/S0108270196000534</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR15</td><td>BibArticle</td><td>Flippen-Anderson JL, Deschamps JR, Ward KB, George C, Houghten R. The crystal structure of deltakephalin: a &#948;-selective opioid peptide with a novel &#946;-bend-like conformation.<Emphasis Type="Italic">Int J Pept Protein Res</Emphasis>. 1994;44:97&#8211;104.</td><td><a href=http://dx.doi.org/10.1111/j.1399-3011.1994.tb00563.x>10.1111/j.1399-3011.1994.tb00563.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR16</td><td>BibArticle</td><td>Fournie-Zaluski M, Prange T, Pascard C, Roques BP. Enkephalin related fragments: conformational studies of the tetrapeptides Tyr-Gly-Gly-Phe and Gly-Gly-Phe-X (X=Leu, Met) by X-ray and<Superscript>1</Superscript>H NMR spectroscopy.<Emphasis Type="Italic">Biochem Biophys Res Commun</Emphasis>. 1977;79:1199&#8211;1206.</td><td>&nbsp;</td><td><a href=http://dx.doi.org/10.1016/0006-291X(77)91133-0>10.1016/0006-291X(77)91133-0</a></td><td><b>CrossRef-Meta</b></td>
<td>Author_FamilyName_2, Year, VolumeID, FirstPage</td><td>CrossRef</td></tr><tr><td>CR17</td><td>BibArticle</td><td>Flippen-Anderson JL, Deschamps JR, George C, Hruby VJ, Misicka A, Lipkowski AW. Crystal structure of biphalin&#8212;multireceptor opioid peptide.<Emphasis Type="Italic">J Pept Res</Emphasis>. 2002;59:123&#8211;133.</td><td><a href=http://dx.doi.org/10.1034/j.1399-3011.2002.01967.x>10.1034/j.1399-3011.2002.01967.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR18</td><td>BibArticle</td><td>Flippen-Anderson JL, George C, Deschamps JR, Reddy PA, Lewin AH, Brine GA. X-ray structures of a potent &#948;-receptor selective opioid antagonist and a protected form of the &#948;-receptor antagonist ICI 174,864.<Emphasis Type="Italic">Lett Pept Sci</Emphasis>. 1994;1:107&#8211;115.</td><td><a href=http://dx.doi.org/10.1007/BF00128528>10.1007/BF00128528</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR19</td><td>BibArticle</td><td>Flippen-Anderson JL, Hruby VJ, Collins N, George C, Cudney B. X-ray structure of [D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]enkephalin, a highly potent, delta-opioid receptor-selective compound: comparisons with proposed solution conformations.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1994;116:7523&#8211;7531.</td><td><a href=http://dx.doi.org/10.1021/ja00096a008>10.1021/ja00096a008</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR20</td><td>BibArticle</td><td>Collins N, Flippen-Anderson JL, Haaseth R, et al. Conformational determinants of agonist versus antagonist properties of [D-Pen<Superscript>2</Superscript>, D-Pen<Superscript>5</Superscript>]-enkephalin (DPDPE) analogs at opioid receptors: comparison of x-ray crystallographic structure, solution<Superscript>1</Superscript>H NMR data, and molecular dynamic simulations of [L-Ala<Superscript>3</Superscript>]DPDPE and [D-Ala<Superscript>3</Superscript>]DPDPE.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1996;118:2143&#8211;2152.</td><td><a href=http://dx.doi.org/10.1021/ja9531081>10.1021/ja9531081</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR21</td><td>BibArticle</td><td>Nikiforovich GV, Kover KE, Kolodziej SA, et al. Design and comprehensive conformational studies of Tyr<Superscript>1</Superscript>-cyclo(D-Pen<Superscript>2</Superscript>-Gly<Superscript>3</Superscript>-Phe<Superscript>5</Superscript>-l-3-Mpt<Superscript>5</Superscript>) and Tyr(1)-cyclo(Pen<Superscript>2</Superscript>-Gly<Superscript>3</Superscript>-Phe<Superscript>5</Superscript>-d-3-Mpt<Superscript>5</Superscript>): novel conformationally constrained opioid peptides.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1996;118:959&#8211;969.</td><td><a href=http://dx.doi.org/10.1021/ja952964+>10.1021/ja952964+</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR22</td><td>BibArticle</td><td>Lomize AL, Flippen-Anderson JL, George C, Mosberg HI. Conformational-analysis of the delta-receptor-selective, cyclic opioid peptide, Tyr-cyclo[D-Cys-Phe-D-Pen]OH (JOM-13): comparison of X-ray crystallographic structures, molecular mechanics simulation, and<Superscript>1</Superscript>H-NMR data.<Emphasis Type="Italic">J Am Chem Soc</Emphasis>. 1994;116:429&#8211;436.</td><td><a href=http://dx.doi.org/10.1021/ja00081a001>10.1021/ja00081a001</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR23</td><td>BibArticle</td><td>Flippen-Anderson JL, Deschamps JR, George C, et al. X-ray structure of Tyr-D-Tic-Phe-Phe-NH<Subscript>2</Subscript> (D-TIPP-NH<Subscript>2</Subscript>), a highly potent &#956;-receptor selective opioid agonist: comparisons with proposed model structures.<Emphasis Type="Italic">J Pept Res</Emphasis>. 1997;49:384&#8211;393.</td><td><a href=http://dx.doi.org/10.1111/j.1399-3011.1997.tb00890.x>10.1111/j.1399-3011.1997.tb00890.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR24</td><td>BibArticle</td><td>Ciajolo MR, Balboni G, Picone D, et al. A solution and solid-state structure of the diketopiperazine of tyrosyl-tetrahydroisoquinoline-3-carboxylic acid.<Emphasis Type="Italic">Int J Pept Protein Res</Emphasis>. 1995;46:134&#8211;138.</td><td><a href=http://dx.doi.org/10.1111/j.1399-3011.1995.tb01328.x>10.1111/j.1399-3011.1995.tb01328.x</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR25</td><td>BibArticle</td><td>Deschamps JR, Flippen-Anderson JL, George C. 2-[N-(<Emphasis Type="Italic">t</Emphasis>-Butoxy carbonyl)tyrosyl]-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid nitromethane solvate.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 2001;57E:o87-o90.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR26</td><td>BibArticle</td><td>Deschamps JR, Flippen-Anderson JL, Moore C, Cudney R, George C. Tyrosyl-D-tetrahydroisoquinoline-3-carboxylic acid and tyrosyl-D-tetrahydroisoquinoline-3-carboxamide.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1997;C53:1478&#8211;1482.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR27</td><td>BibArticle</td><td>Bryant SD, George C, Flippen-Anderson JL, et al. Crystal structures of dipeptides containing the DMT-TIC pharmacophore.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2002;45:5506&#8211;5513.</td><td><a href=http://dx.doi.org/10.1021/jm020330p>10.1021/jm020330p</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR28</td><td>BibArticle</td><td>Petsko GA. On the other hand&#8230;.<Emphasis Type="Italic">Science</Emphasis>. 1992;256:1403&#8211;1404.</td><td><a href=http://dx.doi.org/10.1126/science.1604313>10.1126/science.1604313</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR29</td><td>BibArticle</td><td>Milton RC, Milton SCF, Kent BBH. Total chemical synthesis of a D-enzyme: the enantiomers of HIV-1 protease show demonstration of reciprocal chiral substrate specificity.<Emphasis Type="Italic">Science</Emphasis>. 1992;256:1445&#8211;1448.</td><td><a href=http://dx.doi.org/10.1126/science.1604320>10.1126/science.1604320</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR30</td><td>BibArticle</td><td>Coster D, Knol KS, Prins JA. Unterschiede in der intensit&#228;t der r&#246;ntgenstrahlen-feflexion an den beiden 111-fl&#228;chen der zinkblende.<Emphasis Type="Italic">Z Phys</Emphasis>. 1930;63:345&#8211;369.</td><td><a href=http://dx.doi.org/10.1007/BF01339610>10.1007/BF01339610</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR31</td><td>BibArticle</td><td>Bijvoet JM, Peerdeman AF, van Bommel AJ. Determination of the absolute configuration of optically active compounds by means of X-rays.<Emphasis Type="Italic">Nature</Emphasis>. 1951;168:271&#8211;272.</td><td><a href=http://dx.doi.org/10.1038/168271a0>10.1038/168271a0</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR32</td><td>BibArticle</td><td>Flack HD. On enantiomorph-polarity estimation.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1983;A39:876&#8211;881.</td><td><a href=http://dx.doi.org/10.1107/S0108767383001762>10.1107/S0108767383001762</a></td><td>&nbsp;</td><td><b>CrossRef-Meta</b></td>
<td>Year, Author_FamilyName_1, ArticleTitle, FirstPage</td><td>CrossRef</td></tr><tr><td>CR33</td><td>BibArticle</td><td>Schiller PW, Nguyen TMD, Weltrowska G, et al. Differential stereochemical requirments of &#956; vs &#948; opioid receptors for ligand binding and signal transduction: development of a class of potent and highly &#948;-selective peptide antagonists.<Emphasis Type="Italic">Proc Natl Acad Sci USA</Emphasis>. 1992;89:11871&#8211;11875.</td><td><a href=http://dx.doi.org/10.1073/pnas.89.24.11871>10.1073/pnas.89.24.11871</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR34</td><td>BibArticle</td><td>Balboni G, Guerrini R, Salvadori S, et al. Evaluation of the Dmt-Tic pharmacophore: conversion of a potent delta-opioid receptor antagonist into a potent delta agonist and ligands with mixed properties.<Emphasis Type="Italic">J Med Chem</Emphasis>. 2002;45:713&#8211;720.</td><td><a href=http://dx.doi.org/10.1021/jm010449i>10.1021/jm010449i</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR35</td><td>BibArticle</td><td>Eddy NB, May EL. The search for a better analgesic.<Emphasis Type="Italic">Science</Emphasis>. 1973;181:407&#8211;414.</td><td><a href=http://dx.doi.org/10.1126/science.181.4098.407>10.1126/science.181.4098.407</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR36</td><td>BibArticle</td><td>Schiller PW, Yam CF, Lis M. Evidence of topographical analogy between methionine-enkephalin and morphine derivatives.<Emphasis Type="Italic">Biochemistry</Emphasis>. 1977;16:1831&#8211;1838.</td><td><a href=http://dx.doi.org/10.1021/bi00628a011>10.1021/bi00628a011</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR37</td><td>BibArticle</td><td>Gylbert L. The crystal and molecule structure of morphine hydrochloride trihydrate.<Emphasis Type="Italic">Acta Crystallogr</Emphasis>. 1973;B29:1630&#8211;1635.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR38</td><td>BibBook</td><td>Thomas G.<Emphasis Type="Italic">Medicinal Chemistry: An Introduction</Emphasis>. Chichester, UK: John Wiley &amp; Sons; 2000.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR39</td><td>BibBook</td><td>Foye WO, Lemke TL, Williams DA.<Emphasis Type="Italic">Principles of Medicinal Chemistry</Emphasis>. Baltimore, MD: Williams &amp; Wilkins; 1995.</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td><td>&nbsp;</td></tr><tr><td>CR40</td><td>BibArticle</td><td>Michel AG, Evrard G, Norberg B, Milchert E. Molecular-Structure of Opiate Alkaloids. 2. Crystal-Structures of 4-Methylhomobenzomorphan Hydrobromide (I) and 4,12-beta-Dimethylhomobenzomorphan (II).<Emphasis Type="Italic">Can J Chem</Emphasis>. 1988;66:1763&#8211;1769.</td><td><a href=http://dx.doi.org/10.1139/v88-284>10.1139/v88-284</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR41</td><td>BibArticle</td><td>Thomas JB, Zheng XL, Mascarella SW, et al. N-substituted 9&#946;-methyl-5-(3-hyroxyphenyl)morphans are opioid receptor pure antagonists.<Emphasis Type="Italic">J Med Chem</Emphasis>. 1998;41:4143&#8211;4149.</td><td><a href=http://dx.doi.org/10.1021/jm980290i>10.1021/jm980290i</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR42</td><td>BibArticle</td><td>Hashimoto A, Jabobson AE, Rothman RB, et al. Probes for narcotic receptor mediated phenomena. 28. New opioid antagonists from enantiomeric analogues of<Emphasis Type="Italic">m</Emphasis>-hydroxyphenyl-N-phenylethylmorphan.<Emphasis Type="Italic">Bioorg Med Chem</Emphasis>. 2002;10:3319&#8211;3329.</td><td><a href=http://dx.doi.org/10.1016/S0968-0896(02)00219-5>10.1016/S0968-0896(02)00219-5</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR43</td><td>BibArticle</td><td>Flippen-Anderson JL, George C, Bertha CM, Rice KC. X-ray crystal structures of potent opioid receptor ligands: etonitazene,<Emphasis Type="Italic">cis</Emphasis>-(+)-3-methylfentanyl, etorphine, diprenorphine, and buprenorphine.<Emphasis Type="Italic">Heterocycles</Emphasis>. 1994;39:751&#8211;766.</td><td><a href=http://dx.doi.org/10.3987/COM-94-S(B)70>10.3987/COM-94-S(B)70</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr><tr><td>CR44</td><td>BibArticle</td><td>Hruby VJ, Gehrig CA. Recent developments in the design of receptor specifico-peptides.<Emphasis Type="Italic">Med Res Rev</Emphasis>. 1989;9:343&#8211;401.</td><td><a href=http://dx.doi.org/10.1002/med.2610090306>10.1002/med.2610090306</a></td><td>&nbsp;</td><td><b>SpringerLink</b></td>
<td align=center>---</td><td align=center>---</td></tr></table>